TSHA — TAYSHA GENE THERAPIES INC

Ownership history in Quantum Private Wealth, LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which Quantum Private Wealth, LLC reported a position in TAYSHA GENE THERAPIES INC (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.32% (2025 Q4)
Avg. % of fund
0.54%
First filed
2022 Q1
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 819,715 -2,361 -0.3% 1.32% $4.5M $5.50
2025 Q3 ADDED 822,076 +6,100 +0.7% 0.79% $2.7M $3.27
2025 Q2 ADDED 815,976 +24,500 +3.1% 0.61% $1.9M $2.31
2025 Q1 REDUCED 791,476 -3,500 -0.4% 0.42% $1.1M $1.39
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.31% Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33%
← Back to Quantum Private Wealth, LLC Holdings